$FRX Headlines Earnings boost Micron, drag on Container

New Post Public Reply Private Reply Replies (0) Message Board

Jan 15, 2014 at 1:18 PM

$FRX Headlines

Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
U.S. stocks end lower after Fed minutes 4:24 p.m. Jan. 8, 2014 - Anora Mahmudova
Stock market live blog (recap): Dow, S&P 500 end lower after Fed minutes 4:04 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Forest shares see double-digit gains following Aptalis purchase 11:03 a.m. Jan. 8, 2014 - Russ Britt
Forest Laboratories acquires Aptalis for $2.9 bln 7:50 a.m. Jan. 8, 2014 - Saumya Vaishampayan
Forest Laboratories acquires Aptalis for $2.9 bln 7:45 a.m. Jan. 8, 2014 - Saumya Vaishampayan
Facebook, Twitter, Yahoo are stocks to watch 1:57 p.m. Dec. 24, 2013 - Wallace Witkowski
Stocking stuffer stocks for 2014 10:52 a.m. Dec. 23, 2013 - The Trading Deck
S&P shifts to ‘good news is good news’ backdrop 12:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Dow set to open below 16,000; Apple rises 8:53 a.m. Dec. 3, 2013 - William L. Watts
Forest Laboratories to cut 9% of workforce 11:39 p.m. Dec. 2, 2013 - MarketWatch.com
EBay outperforms Amazon on Cyber Monday 4:16 p.m. Dec. 2, 2013 - Sue Chang
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - Russ Britt
Forest Labs to cut $500 mln in costs, R&D 9:55 a.m. Dec. 2, 2013 - MarketWatch.com
Apple snaps winning streak; Netflix rewinds 3:59 p.m. Oct. 22, 2013 - Sue Chang
Changing of the guard at Forest Labs placates Icahn — for now 3:50 p.m. Sept. 10, 2013 - Russ Britt
Forest Labs Fetzima Gets FDA OK on depression drug 8:06 a.m. July 26, 2013 - MarketWatch.com
Forest Labs investors see the light; swing shares to a gain near close 2:38 p.m. July 23, 2013 - Russ Britt
Centene, Forest each beat earnings views, but diverge in market woods 10:16 a.m. July 23, 2013 - Russ Britt
Forest Labs net falls 58% on lower Lexapro sales 7:06 a.m. July 23, 2013 - MarketWatch.com

Richter brushes off Forest speculation 8:33 a.m. Jan. 14, 2014 - Seeking Alpha
Why Forest Laboratories (FRX) is Poised to Beat Earnings Estimates Again - Tale of the Tape 8:45 a.m. Jan. 13, 2014 - Zacks.com
Ironwood Up on Job Cut Plans - Analyst Blog 6:30 p.m. Jan. 10, 2014 - Zacks.com
Aegerion Gives Preliminary 2013 Update - Analyst Blog 5:10 p.m. Jan. 10, 2014 - Zacks.com
ENDP Agrees to Sell HealthTronics Unit - Analyst Blog 11:40 a.m. Jan. 10, 2014 - Zacks.com
SA PRO: Top Long And Short Ideas, Thursday January 9 7:30 a.m. Jan. 10, 2014 - Seeking Alpha
NuPathe Soars on Teva Offer - Analyst Blog 3:05 p.m. Jan. 9, 2014 - Zacks.com
Forest Labs Soars on Aptalis Deal - Analyst Blog 1:10 p.m. Jan. 9, 2014 - Zacks.com
Update on AMAG's Feraheme - Analyst Blog 1:00 p.m. Jan. 9, 2014 - Zacks.com
Positive Data on BioSpecifics/ Auxilium's Xiaflex - Analyst Blog 12:10 p.m. Jan. 9, 2014 - Zacks.com
NPSP Provides Rosy Gattex Outlook, Shares up - Analyst Blog 11:40 a.m. Jan. 9, 2014 - Zacks.com
Forest Branches Out With $2.9B Purchase of Rival 9:48 a.m. Jan. 9, 2014 - Barrons.com
Wall Street Breakfast: Must-Know News 6:33 a.m. Jan. 9, 2014 - Seeking Alpha
New Data on Pacira's Exparel - Analyst Blog 6:11 p.m. Jan. 8, 2014 - Zacks.com
Oculus Introduces Two Products - Analyst Blog 5:10 p.m. Jan. 8, 2014 - Zacks.com
AZN and Horizon Discovery Ink Deal - Analyst Blog 5:02 p.m. Jan. 8, 2014 - Zacks.com
Affymetrix Up on Upbeat Rev Guidance - Analyst Blog 4:45 p.m. Jan. 8, 2014 - Zacks.com
FDA lists four new drugs mentioned in Paragraph IV ANDAs 3:59 p.m. Jan. 8, 2014 - Seeking Alpha
Valeant Provides Strong Guidance, Shares Up - Analyst Blog 2:20 p.m. Jan. 8, 2014 - Zacks.com
Forest Buying Aptalis; Teva Bids For NuPathe Vs. Endo 10:24 a.m. Jan. 8, 2014 - Investors Business Daily

Forest Laboratories Pursues Additional Market Exclusivity to Extend Namenda Patent 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Adamas Pharmaceuticals Earns $40 Million in Milestone Payments from Forest Laboratories for MDX-8704 9:00 a.m. Jan. 9, 2014 - PR Newswire
Trevena Announces Dosing of First Patient in Phase 2b BLAST-AHF Trial of TRV027 for Acute Heart Failure 6:59 a.m. Jan. 9, 2014 - BusinessWire
Aptalis to be Acquired by Forest Laboratories for $2.9 Billion 7:36 a.m. Jan. 8, 2014 - BusinessWire
Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash 7:29 a.m. Jan. 8, 2014 - BusinessWire
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
moksha8 files for regulatory approval of Viibryd® and Colobreathe in Brazil and amends alliance with Forest Laboratories 8:00 a.m. Jan. 6, 2014 - PR Newswire
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 Third Quarter Earnings 3:59 p.m. Jan. 2, 2014 - BusinessWire
Drug Availability, Clinical Trial Partnerships, Labeling Discussions, Stock Updates, and Credit Facilities - Research Report on Forest Laboratories, Oxygen Biotherapeutics, Alimera, pSivida and AcelRx 8:00 a.m. Dec. 24, 2013 - PR Newswire
Forest Announces New FETZIMA(TM) (levomilnacipran ER capsules) Now Available in Pharmacies Throughout U.S. 8:00 a.m. Dec. 19, 2013 - BusinessWire
Stock Price Updates, Dividends Declaration, and Appointments in Executive Leadership Team - Research Report on Humana, Illumina, Forest Laboratories, Stryker, and Unilife 8:00 a.m. Dec. 16, 2013 - PR Newswire
Forest Laboratories Announces Appointments to its Executive Team 9:00 a.m. Dec. 9, 2013 - BusinessWire
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin 8:00 a.m. Dec. 6, 2013 - PR Newswire
Forest Laboratories, Inc. Upsizes and Prices Offering of $1.2 Billion of Senior Notes Due 2021 4:36 p.m. Dec. 5, 2013 - BusinessWire
Marketing Rights Acquisitions, PDUFA Date Extensions, Accountable Care Relationship and Stock Price Updates - Research Report on Forest Laboratories, Biogen, Bristol-Myers, Express Scripts, and Aetna 8:00 a.m. Dec. 5, 2013 - PR Newswire
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck 9:00 a.m. Dec. 2, 2013 - BusinessWire
Forest Laboratories, Inc. Announces Private Placement of Senior Notes and Amendment to Existing $750 Million Revolver 8:30 a.m. Dec. 2, 2013 - BusinessWire
Forest Announces Major New Plans to Streamline Operations, Leverage Balance Sheet and Repurchase Common Stock 8:30 a.m. Dec. 2, 2013 - BusinessWire
Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare 8:00 a.m. Nov. 27, 2013 - PR Newswire
Today's Research: Celgene Corp., Forest Laboratories Inc., Edwards Lifesciences Corp., and Peregrine Pharma Inc. 1:30 p.m. Nov. 22, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aviator Nation Teams with NFL for 2026 Collection Launch

In a move blending sports with a dash of retro flair, Aviator Nation's dropping its first NFL-licensed collection. They’re looking to serve up a blend of vintage vibes and team spirit. Aviator Nation's New Venture Launching their collection on September 24th, 2026, Aviator Nation takes a dive deeper into sports licensing, after scoring a touchdown (literally!) with an...

NSF Backs New Space Projects: Cooling & Drug Delivery

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

Spotlight on AI-Powered Smart Homes for 2027

Gearing Up for the Connected Home Revolution Ah, the thrill of peering into the future of smart homes! That's what's cookin' as Parks Associates gears up for its annual CONNECTIONS™ Conference slated for May 4-6, 2027. This isn't just another routine pow-wow. Nope, this get-together is about seeing who's leading the pack in transforming our everyday spaces into...

Miguel Pantoja: Wiring a Second Chance Beyond Bars

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Lincoln Educational Services Faces Securities Fraud Suit

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Brands Must Choose: Cost or Value Leadership?

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Rise Treatment Center Launches in Vegas for Teens

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

illycaffè's B Corp™ Recertification Reflects Bold Commitment

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Amy Wilson Joins ITSA Board: A New Era for UBI?

An Unexpected Turn in the UBI Movement In a world where tech and economic security must dance together, minding the steps is crucial. And this time, Amy Wilson's got her dancing shoes on. On September 24, 2026, the Income To Support All (ITSA) Foundation made some waves by adding Wilson to its board of directors, a move showing they're more serious than ever about...

VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...